News & Events

October 22, 2018

The Bowdoin Group Expands to West Coast with Appointment of Principal, Talent Acquisition Services

WALTHAM, Mass. – October 23, 2018 – The Bowdoin Group, an executive search firm with deep expertise in leadership search and strategic build-outs for innovative companies, is pleased to announce the appointment of Lori Smudsky as a Principal, Talent Acquisition Services based in San Francisco.…

October 11, 2018

The Bowdoin Group Completes President Search for Norwalk, CT-based HealthPrize Technologies

NORWALK, Conn.–(BUSINESS WIRE)– HealthPrize Technologies, the leading cloud-based patient engagement and adherence platform for life science companies, announced today the appointment of John Monahan to the newly-created role of President. Monahan brings more than 25 years of relevant experience in operations, client services, sales and marketing to this role.…

July 31, 2018

The Bowdoin Group Adds Two Strategic Hires to Team

WALTHAM, Mass., July 31, 2018 – The Bowdoin Group, an executive search firm with deep expertise in leadership search and strategic build-outs for innovative companies, announced the expansion of their growth efforts, including the strategic hiring of a new Principal based in New York City and a Head of Marketing to lead strategic efforts.…

June 13, 2018

Karen Walker Beecher Leads Panel Discussion on Pay Equity and Challenges in #MeToo Era

How are leaders responding in the face of strong cultural forces like #MeToo, pay equity, and performance? Join The Bowdoin Group and Marsh & McLennan Agency for Part IV in our series for an interactive and energizing session designed exclusively for executives and HR leaders as a local panel of experts share how they are responding to these dynamics.…

May 15, 2018

The Bowdoin Group and NEVCA Team Up for “VC Briefing: Cross-Industry Hiring & Building Great Teams”

Join The Bowdoin Group and the New England Venture Capital Association (NEVCA) for lunch and an in-depth, interactive conversation on what it takes to build great teams and companies – with a focus on cross-industry hiring in FinTech, Digital Health, and beyond.…

April 20, 2018

The Bowdoin Group ranked in Forbes’ 2018 Best Executive Recruiting Firms

WALTHAM, Mass., April 20, 2018 – The Bowdoin Group, an executive search firm with deep expertise in leadership search and strategic build-outs for innovative companies, was ranked #186 in Forbes’ 2018 Best Executive Recruiting Firms. The firm was last ranked #199 in Forbes 2017 Best Recruiters – Professional Search.…

February 15, 2018

Executive Search Firm, The Bowdoin Group, Wins Inavero’s 2018 Best of Staffing® Client and Talent Awards for the Fifth Consecutive Year

WALTHAM, Mass., February 15, 2018 – The Bowdoin Group, an executive search firm with expertise in leadership search and strategic build-outs for innovative companies, has announced today that it has earned Inavero’s Best of Staffing® Client and Talent Awards for providing superior service.…

September 16, 2017

The Bowdoin Group Ranked in Massachusetts Largest Executive Search Firms in 2016

WALTHAM, Mass., September 16, 2017 – The Bowdoin Group, an executive search firm with expertise in executive search and strategic team expansions for innovative companies, was named to the Boston Business Journal’s “Largest Executive Search Firms in Massachusetts” for 2016. The executive search firms highlighted in this list were were determined by revenue generated by executive-level searches (defined by the BBJ as full-time executive-level jobs paying at least $100,000/year) in Massachusetts.…

September 11, 2017

OTHER NEWS: Archway Health Bolsters Team Ahead of Expected New Bundled Payments Programs from CMS

WATERTOWN, Mass., – September 7, 2017 – With an expected announcement of a new bundled payments program from the Centers for Medicare and Medicaid Services (CMS), Archway Health has hired four new team members to bolster and expand the organization’s capabilities, operations, and client services.…

August 28, 2017

OTHER NEWS: Apellis Pharmaceuticals Announces that APL-2 Met its Primary Endpoint in a Phase 2 Study

LOUISVILLE, Ky., August 24, 2017 – Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a platform of novel therapeutic compounds for the treatment of autoimmune diseases, today announced that its complement C3 inhibitor, APL-2, met its primary endpoint in a Phase 2 clinical trial (FILLY) in patients with geographic atrophy (GA) associated with age-related macular degeneration (AMD).…

Explore how we can identify the ideal candidate for your position